PRTA

10.05

2.43% -0.25

시간 외 거래: 9.85 -0.20 -1.99%

Prothena Corporation Plc (PRTA)

개요 뉴스 가격 이력 옵션 체인 Financials PRTA 왜 하락? 토론 예측

전일 마감가:

$10.30

열려 있는:

$10.34

하루 거래량:

733.91K

Relative Volume:

0.81

시가총액:

$540.99M

수익:

$217.25M

순이익/손실:

$-50.92M

주가수익비율:

-10.05

EPS:

-1

순현금흐름:

$-100.85M

1주 성능:

+1.31%

1개월 성능:

+21.01%

6개월 성능:

+3.72%

1년 성능:

-40.11%

1일 변동 폭

$9.98

$10.45

1주일 범위

$9.77

$10.65

52주 변동 폭

$4.32

$18.88

Prothena Corporation Plc Stock (PRTA) Company Profile

명칭

Prothena Corporation Plc

부문

Healthcare (1141)

산업

Biotechnology (637)

전화

011-353-1-236-2500

주소

77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2

직원

163

트위터

@ProthenaCorp

다음 수익 날짜

2025-02-18

최신 SEC 제출 서류

PRTA's Discussions on Twitter

PRTA을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
PRTA Prothena Corporation Plc	10.05	554.45M	217.25M	-50.92M	-100.85M	-1.00
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-05-28	다운그레이드	BofA Securities	Neutral → Underperform
2025-05-27	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2025-05-27	다운그레이드	Jefferies	Buy → Hold
2025-05-27	다운그레이드	Oppenheimer	Outperform → Perform
2024-12-20	개시	Chardan Capital Markets	Buy
2024-01-30	다운그레이드	BofA Securities	Buy → Neutral
2023-12-12	개시	Deutsche Bank	Buy
2023-04-24	개시	SVB Securities	Outperform
2023-01-27	개시	Piper Sandler	Overweight
2022-11-04	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-09-28	업그레이드	BofA Securities	Neutral → Buy
2021-11-19	개시	JMP Securities	Mkt Outperform
2021-06-18	업그레이드	BofA Securities	Underperform → Neutral
2021-06-08	재확인	Oppenheimer	Outperform
2021-05-26	개시	Citigroup	Buy
2021-02-26	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2021-02-12	업그레이드	Jefferies	Hold → Buy
2021-02-02	업그레이드	BTIG Research	Neutral → Buy
2020-12-07	개시	H.C. Wainwright	Buy
2020-07-09	업그레이드	Oppenheimer	Perform → Outperform
2019-11-19	업그레이드	Evercore ISI	In-line → Outperform
2018-05-21	다운그레이드	Barclays	Equal Weight → Underweight
2018-04-23	다운그레이드	Jefferies	Buy → Hold
2018-04-05	재확인	Barclays	Overweight
2017-11-20	다운그레이드	Wedbush	Outperform → Neutral
2017-09-29	재확인	BTIG Research	Buy
2017-09-15	개시	RBC Capital Mkts	Outperform
2017-08-17	개시	Evercore ISI	Outperform
2017-07-11	개시	Jefferies	Buy
2017-04-12	개시	Cantor Fitzgerald	Overweight
2017-04-12	개시	Piper Jaffray	Overweight
2017-03-02	개시	Instinet	Buy
2016-12-21	개시	SunTrust	Buy
2016-11-03	개시	Deutsche Bank	Buy
2016-08-04	재확인	Barclays	Overweight
2016-05-13	개시	Barclays	Overweight
2016-02-19	재확인	Wedbush	Outperform
2016-01-21	개시	Credit Suisse	Outperform

모두보기

Prothena Corporation Plc 주식(PRTA)의 최신 뉴스

Oct 10, 2025

Why Prothena Corporation plc stock is seen as undervaluedMarket Performance Report & Daily Stock Momentum Reports - newser.com

Oct 10, 2025

FY2029 EPS Estimates for Prothena Boosted by HC Wainwright - MarketBeat

Oct 10, 2025

Prothena Corporation plc stock volume spike explained2025 Top Decliners & Community Consensus Trade Signals - newser.com

Oct 10, 2025

Oct 09, 2025

What data driven models say about Prothena Corporation plc’s futureMarket Weekly Review & Low Drawdown Trading Techniques - newser.com

Oct 09, 2025

What analysts say about Prothena Corporation plc stockAnalyst Downgrades & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in

Oct 09, 2025

Oct 08, 2025

Prothena stock price target raised to $20 from $14 at H.C. Wainwright - Investing.com Nigeria

Oct 08, 2025

Oct 07, 2025

Prothena Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 07, 2025

Public Employees Retirement System of Ohio Invests $256,000 in Prothena Corporation plc $PRTA - Defense World

Oct 07, 2025

Prothena Corp (PRTA) Sees Raised Price Target by HC Wainwright & Co. | PRTA Stock News - GuruFocus

Oct 07, 2025

Oct 06, 2025

Is now a turning point for Prothena Corporation plcBull Run & Safe Capital Growth Stock Tips - newser.com

Oct 06, 2025

Tools to monitor Prothena Corporation plc recovery probability2025 Momentum Check & Free Community Consensus Stock Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Published on: 2025-10-05 07:33:52 - newser.com

Oct 05, 2025

Leading vs lagging indicators on Prothena Corporation plc performance2025 Analyst Calls & Safe Entry Point Alerts - newser.com

Oct 05, 2025

Evaluating Prothena Corporation plc with trendline analysisWeekly Trade Review & Daily Profit Maximizing Tips - newser.com

Oct 05, 2025

Oct 03, 2025

Published on: 2025-10-03 05:55:14 - newser.com

Oct 03, 2025

How moving averages guide Prothena Corporation plc tradingJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com

Oct 03, 2025

Prothena Corporation plc (NASDAQ:PRTA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Oct 03, 2025

Oct 01, 2025

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986 - PharmiWeb.com

Oct 01, 2025

Prothena's partner Bristol Myers Squibb obtains fast track designation from US FDA for BMS-986446 for treatment of Alzheimer's disease - MarketScreener

Oct 01, 2025

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease - Business Wire

Oct 01, 2025

Sep 30, 2025